Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma

Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma

Glioblastoma (GBM) is the most common brain tumor, with rapid proliferation and fatal invasiveness. Large-scale genetic and epigenetic profiling studies have identified targets among molecular subgroups, yet agents developed against these targets have failed in late clinical development. We obtained...

Full description

Bibliographic Details
Main Authors:	Yi Jin, Zhanwang Wang, Kaimin Xiang, Yuxing Zhu, Yaxin Cheng, Ke Cao, Jiaode Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Genetics
Subjects:	glioblastoma nomogram novel classification WGCNA signature
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.900911/full

Similar Items

A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients
by: Yulin Wang, et al.
Published: (2019-07-01)

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses
by: Shengda Ye, et al.
Published: (2022-09-01)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
by: Yu-Hang Zhang, et al.
Published: (2020-11-01)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
by: Xin Yan, et al.
Published: (2021-06-01)

A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma
by: Xin-Yu Li, et al.
Published: (2021-08-01)

Integrated Analysis to Obtain Potential Prognostic Signature in Glioblastoma
by: Jia-Qi Chen, et al.
Published: (2022-01-01)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
by: Ji’an Yang, et al.
Published: (2020-03-01)

Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients
by: Xiangjun Tang, et al.
Published: (2019-08-01)

Role of alternative splicing signatures in the prognosis of glioblastoma
by: Zu‐cheng Xie, et al.
Published: (2019-12-01)

Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer
by: Yi Jin, et al.
Published: (2023-07-01)

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma
by: Yi Jin, et al.
Published: (2022-07-01)

An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma
by: Sheng Wang, et al.
Published: (2021-03-01)

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma
by: Gang Wang, et al.
Published: (2022-03-01)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
by: Shixian Liu, et al.
Published: (2022-10-01)

Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma
by: Seung Won Choi, et al.
Published: (2018-05-01)

An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin
by: Marta Calvo Tardón, et al.
Published: (2020-09-01)

Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme
by: Jinghua Wang, et al.
Published: (2022-06-01)

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
by: Chunyu Zhang, et al.
Published: (2021-03-01)

Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer
by: Zheng Zhou, et al.
Published: (2019-09-01)

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
by: Zhentao Liu, et al.
Published: (2021-03-01)

A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
by: Rui-Chao Chai, et al.
Published: (2019-09-01)

Improving the overall survival prognosis prediction accuracy: A 9‐gene signature in CRC patients
by: Wenbo Zheng, et al.
Published: (2021-09-01)

Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling
by: Liang Zhao, et al.
Published: (2021-01-01)

Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis
by: Zheng He, et al.
Published: (2020-09-01)

Identification of a Five-mRNA Signature as a Novel Potential Prognostic Biomarker for Glioblastoma by Integrative Analysis
by: Huifang Xu, et al.
Published: (2022-07-01)

Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival
by: Mariana Brutschin Pereira, et al.
Published: (2018-06-01)

Identification of key modules and hub genes in glioblastoma multiforme based on co‐expression network analysis
by: Chun Li, et al.
Published: (2021-03-01)

Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients
by: Wei-Zhen Gao, et al.
Published: (2018-12-01)

Development and validation of a four‐lipid metabolism gene signature for diagnosis of pancreatic cancer
by: Yanrong Ye, et al.
Published: (2021-11-01)

Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma
by: Zong-Qing Zheng, et al.
Published: (2023-05-01)

A Multielement Prognostic Nomogram Based on a Peripheral Blood Test, Conventional MRI and Clinical Factors for Glioblastoma
by: Changjun Rao, et al.
Published: (2022-02-01)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
by: Ruiliang Wang, et al.
Published: (2021-06-01)

Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion via EMT pathway
by: Gui-Qiang Yuan, et al.
Published: (2024-07-01)

Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers
by: Chao Yang, et al.
Published: (2022-06-01)

T cell-mediated tumor killing based signature to predict the prognosis and immunotherapy for glioblastoma
by: Hongchao Liu, et al.
Published: (2024-05-01)

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
by: Xiao Yang, et al.
Published: (2022-02-01)

Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer
by: Rongjia Su, et al.
Published: (2022-05-01)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
by: Shaobo Mo, et al.
Published: (2021-06-01)

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma
by: Ao Zhang, et al.
Published: (2023-07-01)

A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
by: Xiaomeng Li, et al.
Published: (2021-02-01)